Position in SABS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$140,017
+$138,118 QoQ
Shares Held
35,902
+7138.3% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 86 holders
Holding Since
Mar 2023
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SABS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,204,586 across 455 Biotechnology names. SABS ranks #229 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in SABS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $140,017 | 35,902 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,899 | 496 | Shares | Defined | 2026-05-15 | |
| 2024-09-30 | $27 | 10 | Shares | Sole | 2026-03-31 | |
| 2023-03-31 | $23 | 54 | Shares | Sole | 2026-03-30 | |
| No filing history on record for this holder in this stock. | ||||||